CA2 Pyramidal Neurons describes a neural cell population with specific vulnerability or functional significance in neurodegenerative disease. This page covers cell morphology, molecular markers, connectivity, and disease-specific pathological changes.
The CA2 subfield of the hippocampus is anatomically and functionally distinct from the better-studied CA1 and CA3 regions. CA2 pyramidal neurons have unique molecular signatures, connectivity patterns, and—importantly—show distinctive vulnerability in Alzheimer's disease and related dementias.
¶ Anatomy and Location
CA2 occupies a transitional position between CA1 and CA3 within the hippocampal formation:
- Location: Situated between CA1 (distal) and CA3 (proximal) along the hippocampal longitudinal axis
- Boundaries: Separated from CA1 by the stratum lucidum-radiatum border, and from CA3 by the CA2 pyramidal cell layer
- Size: The smallest of the CA fields, comprising approximately 5-10% of hippocampal pyramidal neurons
- Medium-sized pyramidal cell bodies (15-20 μm diameter)
- Dendritic arborization extending into stratum radiatum and stratum lacunosum-moleculare
- Distinct dendritic spine density and distribution compared to CA1/CA3
CA2 neurons exhibit a unique molecular signature that distinguishes them from neighboring subfields:
- STEP (STriatal-Enriched protein tyrosine phosphatase): Highly expressed in CA2
- CALB1 (Calbindin): Lower expression than CA1
- WFA (Wisteria floribunda agglutinin): CA2-specific mossy fiber associated labeling
- PKCγ (Protein Kinase C gamma): Specific to CA2 pyramidal cells
- Reelin: Expressed in CA2 interneurons and some pyramidal cells
- nNOS (neuronal nitric oxide synthase): Present in subset of CA2 neurons
- VP16 and nTRK2: CA2-enriched developmental markers
The CA2 region is critically involved in social memory—the ability to recognize and remember conspecifics:
- Social novelty detection: CA2 neurons respond preferentially to novel social stimuli
- Social discrimination: Required for distinguishing familiar from novel individuals
- Social memory consolidation: Involved in forming long-term social memories
While less studied than CA1 place cells, CA2 pyramidal neurons exhibit:
- Place cell properties: Spatial firing fields in familiar environments
- Remapping: Context-dependent firing pattern changes
- Phase precession: Coupling to theta oscillations
CA2 exhibits unique synaptic properties:
- Resistant to ischemia: CA2 shows greater resistance to hypoxic injury than CA1
- Distinct LTP induction: Requires higher stimulation thresholds
- Modulatory peptide signaling: Vasoactive intestinal peptide (VIP) influences CA2 plasticity
CA2 is emerging as one of the most vulnerable hippocampal subfields in AD:
- Early tau pathology: CA2 shows early tau accumulation before CA1 involvement
- Neuronal loss: Significant CA2 pyramidal neuron loss in early AD stages
- Synaptic dysfunction: Early synaptic alterations before frank neuron loss
- Connectivity disruption: CA2→CA1 circuit disruption correlates with memory deficits
The vulnerability pattern in CA2 differs from CA1:
- More resistant to transient global ischemia than CA1
- More vulnerable in AD than CA1 and CA3
- May represent a "weak link" in hippocampal circuit integrity
- CA2 shows accelerated age-related changes compared to other CA fields
- Dendritic atrophy and spine loss with normal aging
- Functional decline in social memory tasks with age
- CA2 is particularly vulnerable to seizure-induced damage
- Neuronal loss and gliosis in chronic epilepsy
- Altered CA2 inhibitory neuron density
- Associated with social memory deficits
- CA3 (Schaffer collaterals): Major excitatory input
- Entorhinal cortex (Layer II): Direct cortical input via perforant path
- Septal cholinergic nuclei: Modulatory cholinergic input
- Raphe nuclei: Serotonergic modulation
- Locus coeruleus: Noradrenergic input
- CA1 (stratum radiatum): Primary output to CA1 pyramidal neurons
- Subiculum: Secondary output target
- Lateral septum: Social memory circuit component
- Supramammillary nucleus: Modulatory output
- CSF tau markers: CA2-specific tau species under investigation
- MRI volumetry: CA2 atrophy may serve as early AD biomarker
- Social memory enhancement: CA2-targeted interventions for AD-associated social memory deficits
- Neuroprotective strategies: CA2-specific neuroprotective compounds